NCT06605963View on ClinicalTrials.gov

PPV-06 Vaccine in Inflammatory Knee Osteoarthritis

PHASE2Not yet recruitingINTERVENTIONAL

Enrollment

204

Participants

Timeline

Start Date

December 31, 2025

Primary Completion Date

December 31, 2028

Study Completion Date

December 31, 2028

Conditions

Osteoarthritis, Knee

Interventions

DRUG

PPV-06

6 subcutaneous injections at Day 1, Week 4, Week 24, Week 44, Week 64, Week 84

DRUG

Placebo

6 subcutaneous injections at Day 1, Week 4, Week 24, Week 44, Week 64, Week 84

Trial Locations (1)

Unknown

CIC Cochin, Paris

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Peptinov SAS

INDUSTRY